Comments to FDA: PDUFA Share page: Docket Number: FDA-2010-N-0128 CHPA comments on proposed recommendations for the reauthorization of the Prescription Drug User Fee Act. Download Document Issues: OTC Medicines Monograph Reform Rx-to-OTC Switch User Fees Related Posts Comments Comments Regarding Provisions Pertaining to Preventing Access to U.S. Sensitive Personal Data and Government-Related Data Nov 28, 2024 Press Releases and Statements CHPA Responds to Nomination of Dr. Marty Makary for FDA Commissioner Nov 25, 2024 Polibrief Per-and Polyfluoroalkyl Substances (PFAS) Nov 20, 2024